Molybdenum Cofactor Deficiency, Type A

Molybdenum Cofactor Deficiency, Type A is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as: Molybdenum Cofactor Deficiency Type A
Classified under: Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Nervous System Diseases
Nutritional and Metabolic Diseases
Signs and Symptoms
Indicated drugs: Fosdenopterin

Resolves to

Vocabularies

MeSHT001099344SNOMED CT1003367004UMLSC1854988

What you can answer from here — as of November 01, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

1Structured indicationPopulation, line of therapy, route and combination as fields, not prose

3Clinical trialsPhase, status and sponsor resolved per trial

1Drug reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Molybdenum Cofactor Deficiency, Type A share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.